+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable

  • ID: 4766821
  • Report
  • April 2019
  • Region: Global
  • 226 Pages
  • Renub Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
The Next Generation Sequencing Market is Expected to Surpass US$ 30 Billion by the End of Year 2025 with Double Digit CAGR During 2019-2025

FEATURED COMPANIES

  • Illumina
  • Pacific Biosciences
  • Roche
  • Thermo Fisher Scientific
  • MORE

Next Generation Sequencing (NGS) is a recent technology in which billions of DNA strands can be sequenced through massively parallel sequencing. The Next-Generation Sequencing has revolutionized the biological study, with its ultra-high throughput, speed, and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before. The NGS technology is also referred to as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input. The use of NGS in clinical diagnostic is one of the major factors for the future growth of NGS. Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of the year 2025 with double digit CAGR during 2019-2025.

Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened enormous opportunities for the application of next-generation sequencing, which could help the NGS market to grow significantly over the forecast period.

In addition; some of the major factors responsible for the growth of Next Generation Sequencing are increasing NGS application in the biological study due to its efficient advantage over traditional technologies and growing demand from the drug discovery industry. Additionally, ethical concerns associated with the whole-genome sequencing along with the lack of awareness among people are some of the factors which are expected to restrain the market growth during the forecast period.

This report titled “Next Generation Sequencing Market, Global NGS Forecast by End-User (Academic Research, Healthcare, Biotech / Pharma, Government, Others) Type of Test (Targeted Re-sequencing (TPS/WES), RNA-Sequencing, Whole Genome Sequencing, ChIP-Sequencing, De Novo Sequencing, Methyl-Sequencing) Disease (Reproductive Health, Rare Disease Diagnostics, Oncology (Cancer), Metabolic Immune (Diagnostic), Cardiovascular, Others) Informatics (NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation and Reporting Tools, LIMS Laboratory Information Management System), Reimbursement, Company Analysis (Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, Roche), Platform, Consumable"" provides a complete analysis of global Next Generation Sequencing (NGS) Market. 

Oncology Test Market is the largest among Clinical Next Generation Sequencing Market

In this report, we have defined the next-generation sequencing test market by clinical application. NGS test market is categorized into 6 parts; NGS Test Market by Reproductive Health, NGS Test Market by Rare Disease, NGS Test Market by Oncology, NGS Test Market by Metabolic, NGS Test Market by Cardiovascular and Others NGS Test Market.

Target Re-Sequencing and Whole Exome sequencing is dominating the Clinical Next Generation Sequencing Market

In this report, we have done a complete assessment of different next-generation sequencing technique. Here, we have categorized clinical next-generation sequencing market by type of test into six parts; Targeted Re-sequencing (TPS/WES), Transcriptome (RNA- Sequencing), Whole Genome Sequencing, ChIP- Sequencing, De Novo Sequencing (Novel Organisms) and Methyl-Sequencing.

Next Generation Sequencing Market Trends by Platform

There are several platforms designed for next-generation sequencing for the period of time by top key players. In this report, we have shown the next generation sequencing market by the platform.

Next Generation Sequencing Market Insight by Consumables

In this report, we have done a comprehensive analysis of the NGS market by consumables. There are various kinds of consumable used in next-generation sequencing like a sample, library preparation reagents, kits, automation devices, etc.

Next Generation Sequencing Informatics Market

NGS Informatics is one of the key growth factors that propel the overall NGS market to expand at a rapid pace. In this report, next-generation sequencing informatics market is divided into 6 parts; NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation, and Reporting Tools and Laboratory Information Management System.

Company Analysis

All the companies have been analyzed from the following points: Overview, Recent Developments & Strategy

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Roche
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Illumina
  • Pacific Biosciences
  • Roche
  • Thermo Fisher Scientific
  • MORE

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Driver
4.1.1 Rapid Adoption of NGS in Clinical Application
4.1.2 Advancement in Next Generation Sequencing Platforms
4.1.3 Numerous Growth Factors for Next Generation Sequencing
4.2 Challenges

5. Global Next Generation Sequencing (NGS) Market

6. Market Share - Global Next Generation Sequencing (NGS)
6.1 By End-User
6.2 By Type of Test
6.3 By Disease
6.4 By NGS Informatics Type

7. End-User - Global Next Generation Sequencing Market
7.1 Academic Research
7.2 Healthcare
7.3 Biotech/Pharma
7.4 Government
7.5 Others

8. Type of Test - Global Clinical Next Generation Sequencing Market
8.1 Targeted Re-sequencing (TPS/WES)
8.2 RNA-Sequencing
8.3 Whole Genome Sequencing
8.4 ChIP-Sequencing
8.5 De Novo Sequencing
8.6 Methyl-Sequencing

9. Disease - Global Next Generation Sequencing Test Market
9.1 Reproductive Health
9.2 Rare Disease Diagnostics
9.3 Oncology (Cancer)
9.4 Metabolic Immune (Diagnostic)
9.5 Cardiovascular
9.6 Others

10. Platform - Global Next Generation Sequencing Market

11. Consumable - Global Next Generation Sequencing Market

12. Informatics - Global Next Generation Sequencing Market
12.1 NGS Informatics Services
12.2 Primary and Secondary Data Analysis Tools
12.3 Storage
12.4 Computing
12.5 Biological Interpretation and Reporting Tools
12.6 LIMS (Laboratory Information Management System)

13. Reimbursement

14. Company Analysis
14.1 Illumina
14.1.1 Overview
14.1.2 Recent Development and Strategy
14.2 Thermo Fisher Scientific
14.2.1 Overview
14.2.2 Recent Development and Strategy
14.3 Pacific Biosciences
14.3.1 Overview
14.3.2 Recent Development and Strategy
14.4 Oxford Nanopore Technologies
14.4.1 Overview
14.4.2 Recent Development and Strategy
14.5 Roche
14.5.1 Overview
14.5.2 Recent Development and Strategy

List of Figures:
Figure-01: Global - Next Generation Sequencing (NGS) Market (Million US$), 2018 & 2025
Figure-02: Global - NGS Test Market by Clinical Application Top Two Rapid Growing by Application
Figure-03: Global Next Generation Sequencing (NGS) Market (Million US$), 2015 - 2018
Figure-04: Forecast for Global Next Generation Sequencing (NGS) Market (Million US$), 2019 - 2025
Figure-05: Global: NGS Market Share by End-User (%) 2015 - 2018
Figure-06: Global: Forecast for Next Generation Sequencing (NGS) Market Share by End-User (%) 2019 - 2025
Figure-07: Global: Clinical Next Generation Sequencing Market Share by Type of Test (%) 2015 - 2018
Figure-08: Global: Forecast for Clinical Next Generation Sequencing Market Share by Type of Test (%) 2019 - 2025
Figure-09: Global: Next Generation Sequencing Test Market Share by Clinical Application (%) 2015 - 2018
Figure-10: Global: Forecast for Next Generation Sequencing Test Market Share by Clinical Application (%) 2019 - 2025
Figure-11: Global: NGS Informatics Market Share by Type (%) 2015 - 2018
Figure-12: Global: Forecast for NGS Informatics Market Share by Type (%) 2019 - 2025
Figure-13: Global Next Generation Sequencing (NGS) Market by Academic Research (Million US$), 2015 - 2018
Figure-14: Forecast for Global Next Generation Sequencing (NGS) Market by Academic Research (Million US$), 2019 - 2025
Figure-15: Global Next Generation Sequencing (NGS) Market by Healthcare (Million US$), 2015 - 2018
Figure-16: Forecast for Global Next Generation Sequencing (NGS) Market by Healthcare (Million US$), 2019 - 2025
Figure-17: Global Next Generation Sequencing (NGS) Market by Biotech/Pharma (Million US$), 2015 - 2018
Figure-18: Forecast for Global Next Generation Sequencing (NGS) Market by Biotech/Pharma (Million US$), 2019 - 2025
Figure-19: Global Next Generation Sequencing (NGS) Market by Government (Million US$), 2015 - 2018
Figure-20: Forecast for Global Next Generation Sequencing (NGS) Market by Government (Million US$), 2019 - 2025
Figure-21: Global Next Generation Sequencing (NGS) Market by Others (Million US$), 2015 - 2018
Figure-22: Forecast for Global Next Generation Sequencing (NGS) Market by Others (Million US$), 2019 - 2025
Figure-23: Global Clinical Next Generation Sequencing Market by Targeted Re-sequencing (Million US$), 2015 - 2018
Figure-24: Forecast for Global Clinical Next Generation Sequencing Market by Targeted Re-sequencing (Million US$), 2019 - 2025
Figure-25: Global Clinical Next Generation Sequencing Market by RNA-Sequencing (Million US$), 2015 - 2018
Figure-26: Forecast for Global Clinical Next Generation Sequencing Market by RNA-Sequencing (Million US$), 2019 - 2025
Figure-27: Global Clinical Next Generation Sequencing Market by Whole Genome Sequencing (Million US$), 2015 - 2018
Figure-28: Forecast for Global Clinical Next Generation Sequencing Market by Whole Genome Sequencing (Million US$), 2019 - 2025
Figure-29: Global Clinical Next Generation Sequencing Market by ChIP-Sequencing (Million US$), 2015 - 2018
Figure-30: Forecast for Global Clinical Next Generation Sequencing Market by ChIP-Sequencing (Million US$), 2019 - 2025
Figure-31: Global Clinical Next Generation Sequencing Market by De Novo Sequencing (Million US$), 2015 - 2018
Figure-32: Forecast for Global Clinical Next Generation Sequencing Market by De Novo Sequencing (Million US$), 2019 - 2025
Figure-33: Global Clinical Next Generation Sequencing Market by Methyl-Sequencing (Million US$), 2015 - 2018
Figure-34: Forecast for Global Clinical Next Generation Sequencing Market by Methyl-Sequencing (Million US$), 2019 - 2025
Figure-35: NGS Test Market by Reproductive Health (Million US$), 2015 - 2018
Figure-36: Forecast for NGS Test Market by Reproductive Health (Million US$), 2019 - 2025
Figure-37: NGS Test Market (Rare Disease Diagnostics) (Million US$), 2015 - 2018
Figure-38: Forecast for NGS Test Market (Rare Disease Diagnostics) (Million US$), 2019 - 2025
Figure-39: The Oncology NGS Test Market (Million US$), 2015 - 2018
Figure-40: Forecast for The Oncology NGS Test Market (Million US$), 2019 - 2025
Figure-41: NGS Test Market by Metabolic Immune (Diagnostic) (Million US$), 2015 - 2018
Figure-42: Forecast for USA Dental Market (Spending) (Billion US$) for Titanium, 2019 - 2025
Figure-43: NGS Test Market by Cardiovascular (Million US$), 2015 - 2018
Figure-44: Forecast for NGS Test Market by Cardiovascular (Million US$), 2019 - 2025
Figure-45: Others NGS Test Market (Million US$), 2015 - 2018
Figure-46: Forecast for Others NGS Test Market (Million US$), 2019 - 2025
Figure-47: Global Next Generation Sequencing Market by Platform (Million US$), 2015 - 2018
Figure-48: Forecast for Global Next Generation Sequencing Market by Platform (Million US$), 2019 - 2025
Figure-49: Global Next Generation Sequencing Market by Consumable (Million US$), 2015 - 2018
Figure-50: Forecast for Global Next Generation Sequencing Market by Consumable (Million US$), 2019 - 2025
Figure-51: NGS Informatics Services (Million US$), 2015 - 2018
Figure-52: Forecast for NGS Informatics Services (Million US$), 2019 - 2025
Figure-53: Global NGS Informatics Market by Primary and Secondary Data Analysis Tools (Million US$), 2015 - 2018
Figure-54: Forecast for Global NGS Informatics Market by Primary and Secondary Data Analysis Tools (Million US$), 2019 - 2025
Figure-55: Global NGS Informatics Market by Storage (Million US$), 2015 - 2018
Figure-56: Forecast for Global NGS Informatics Market by Storage (Million US$), 2019 - 2025
Figure-57: Global NGS Informatics Market by Computing (Million US$), 2015 - 2018
Figure-58: Forecast for Global NGS Informatics Market by Computing (Million US$), 2019 - 2025
Figure-59: Global NGS Informatics Market by Biological Interpretation and Reporting Tools (Million US$), 2015 - 2018
Figure-60: Forecast for Global NGS Informatics Market by Biological Interpretation and Reporting Tools (Million US$), 2019 - 2025
Figure-61: Global NGS Informatics Market by LIMS (Laboratory Information Management System) (Million US$), 2015 - 2018
Figure-62: Forecast for Global NGS Informatics Market by LIMS (Laboratory Information Management System) (Million US$), 2019 - 2025

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Roche
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
5 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll